Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 1, 1999, Pages 14-19

  Kleeberger, Cynthia A ^a   Lyles, Robert H ^a   Margolick, Joseph B ^a   Rinaldo, Charles R ^b   Phair, John P ^c   Giorgi, Janis V ^d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELL VIABILITY; CLINICAL TRIAL; CRYOPRESERVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; TISSUE PRESERVATION; VIRUS ISOLATION;

EID: 0032946344     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.1.14-19.1999     Document Type: Article

References (18)

1. Bass, H. Z., J. L. Fahey, P. Nishanian, R. Detels, W. Cumberland, M. Kemeny, and S. Plaeger. 1997. Relation of impaired lymphocyte proliferative function to other major human immunodeficiency virus type 1-induced immunological changes. Clin. Diagn. Lab. Immunol. 4:64-69.
2. Chmiel, J. S., R. Detels, R. Kaslow, M. VanRaden, L. Kingsley, and R. Brookmeyer. 1987. Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. Am. J. Epidemiol. 126:568-577.
3. + cells are not selectively decreased in chronic HIV disease. J. Acquired Immune Defic. Syndr. 7:665-675.
4. Conover, W. J. 1980. Practical nonparametric statistics. John Wiley and Sons, New York, N.Y.
5. Dean, M., M. Carrington, C. Winkler, G. Huttley, M. Smith, R. Allikmets, J. Goedert, S. Buchbinder, E. Vittinghoff, E. Gonperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, C. Rinaldo, R. Detels, Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, Alive Study, and S. O'Brien. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273:1856-1862.
6. Giorgi, J. V., L. E. Hultin, J. A. McKeating, T. Johnson, R. Shih, D. Wiley, B. Owens, J. Lewis, L. Jacobson, J. Phair, S. Wolinsky, and R. Detels. Survival in advanced HIV disease is more stringently related to lymphocyte activation as reflected by expression of CD38 on T cells than to plasma HIV viral burden. Submitted for publication.
7. + cell levels. J. Infect. Dis. 170:775-781.
8. Gjerset, G., K. A. Nelson, and D. M. Strong. 1992. Methods for cryopreserving cells, p. 61-67. In N. R. Rose, E. C. de Macario, J. L. Fahey, H. Friedman, and G. M. Penn (ed.), Manual of clinical laboratory immunology, 4th ed. American Society for Microbiology, Washington, D.C.
9. Huang, Y., W. A. Paxton, S. M. Wolinsky, A. Neumann, L. Zhang, T. He, S. Kang, D. Ceradini, Z. Jin, K. Yazdanbakhsh, K. Kunstman, D. Erickson, E. Dragon, N. Landau, J. Phair, D. Ho, and R. Koup. 1996. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2:1240-1243.
10. Kaslow, R. A., D. G. Ostrow, R. Detels, J. Phair, B. Polk, and C. Rinaldo. 1987. The Multicenter AIDS Cohort Study: rationale, organization and selected characteristics of the participants. Am. J. Epidemiol. 126:310-318.
11. Kaslow, R. A., M. Carrington, R. Apple, L. Park, A. Muñoz, A. Saah, J. Goedert, C. Winkler, S. O'Brien, C. Rinaldo, R. Detels, W. Blattner, J. Phair, H. Erlich, and D. Mann. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 2:405-411.
12. Margolick, J. B., A. Muñoz, A. Donnenberg, L. Park, N. Galai, J. Giorgi, M. O'Gorman, and J. Ferbas. 1995. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. Nat. Med. 1:674-680.
13. Masters, B., and H. Farzadegan. Personal communication.
14. Plaeger, S., H. Bass, P. Nishanian, J. Thomas, N. Aziz, R. Detels, J. King, W. Cumberland, M. Kemeny, and J. Fahey. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes. Clin. Immunol. Immunopathol., in press.
15. Rinaldo, C., X.-L. Huang, Z. Fan, M. Ding, L. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, M. Cottrill, and P. Gupta. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:5838-5842.
16. + cell numbers in progression of HIV-1 infection. AIDS Res. Hum. Retroviruses, in press.
17. Rinaldo, C. R., L. A. Beltz, X. Huang, P. Gupta, Z. Fan, and D. Torpey. 1995. Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men. AIDS Res. Hum. Retroviruses 11:481-489.
18. Zimmerman, P. A., A. Buckler-White, G. Alkhatib, T. Spalding, J. Kubofcik, C. Combadiere, D. Weissman, O. Cohen, A. Rubbert, G. Lam, M. Vaccarezza, P. Kennedy, V. Kumaraswami, J. Giorgi, R. Detels, J. Hunter, M. Chopek, E. Berger, A. Fauci, T. Nutman, and P. Murphy. 1997. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, denned racial background and quantified risk. Mol. Med. 3:23-36.